Linike Medical Group Ltd (LNMG)
4.73
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Linike Medical Group SG&A Expense (Quarterly): 0.0112M for July 31, 2014
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2014 | 0.0112M |
| April 30, 2014 | 0.0198M |
| January 31, 2014 | 0.0382M |
| October 31, 2013 | 0.0245M |
| July 31, 2013 | 0.0601M |
| April 30, 2013 | 0.0789M |
| January 31, 2013 | 0.051M |
| October 31, 2012 | -0.0436M |
| Date | Value |
|---|---|
| July 31, 2012 | 0.0123M |
| April 30, 2012 | 0.0381M |
| January 31, 2012 | 0.0393M |
| October 31, 2011 | 0.0288M |
| July 31, 2011 | 0.0186M |
| April 30, 2011 | 0.0048M |
| January 31, 2011 | 0.0033M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 5.878M |
| Retractable Technologies Inc | 4.158M |
| Xtant Medical Holdings Inc | 20.24M |
| Asensus Surgical Inc | 8.016M |
| Catheter Precision Inc | 2.656M |